AltMountain

Emeryville Bioscience Center REIT, LLC

Boston, MA · CIK 1909161
Status: no Form D since Feb 2022. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Emeryville Bioscience Center REIT, LLC is a real estate fund based in Boston, Massachusetts. According to its most recent Form D, filed Feb 8, 2022, it has sold $125,000 of interests to 125 investors since its first sale in Jan 2022. The minimum investment it accepts from an outside investor is $1,000. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Adam Sichol; Joseph Van Saun; Thomas Shin.

Total raised
$125,000Cumulative sales reported on Form D
Investors
125
First sale
Jan 27, 2022
Minimum investment
$1,000
Who can invest
Not stated
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Adam Sichol; Joseph Van Saun; Thomas Shin
Latest Form D
Feb 8, 2022

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌‌​⁠

Questions about Emeryville Bioscience Center REIT, LLC

What is the minimum investment for Emeryville Bioscience Center REIT, LLC?

According to its latest Form D, filed Feb 8, 2022, the minimum investment Emeryville Bioscience Center REIT, LLC accepts from an outside investor is $1,000.

Who can invest in Emeryville Bioscience Center REIT, LLC?

Emeryville Bioscience Center REIT, LLC is generally open only to investors who meet the eligibility rules in its offering documents. It uses Rule 506(b), which does not allow general advertising.

How much has Emeryville Bioscience Center REIT, LLC raised?

Emeryville Bioscience Center REIT, LLC reports $125,000 sold from 125 investors on its Form D filed Feb 8, 2022. This is cumulative sales since the offering began, not current assets or performance.

Where is Emeryville Bioscience Center REIT, LLC based?

Emeryville Bioscience Center REIT, LLC is based in Boston, Massachusetts.

When did Emeryville Bioscience Center REIT, LLC launch?

Emeryville Bioscience Center REIT, LLC reports its first sale in Jan 2022.

Size compared with every real estate fund

Raised more than 23% of the 214 real estate funds based in Massachusetts, and more than 8% of all 7,334 that report sales.

More real estate funds in Boston

Similar-size real estate funds in Massachusetts

All real estate funds in Massachusetts